Evidence map›Paper›PMID 26258684›Full record

ArticlePloS one2015

Parity and longevity of Aedes aegypti according to temperatures in controlled conditions and consequences on dengue transmission risks.

Daniella Goindin, Christelle Delannay, Cédric Ramdini, Joël Gustave, Florence Fouque

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. AntiviralmBio · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Journal of virology · 2023
    Article
  18. Article
  19. Article
  20. Review of Importance of Weather and Environmental Variables in Agent-Based Arbovirus Models.International journal of environmental research and public health · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniella GoindinLaboratory of Medical Entomology, Unit Environment and Health, Institut Pasteur de la Guadeloupe, 97183 Les Abymes, Guadeloupe.
Christelle DelannayLaboratory of Medical Entomology, Unit Environment and Health, Institut Pasteur de la Guadeloupe, 97183 Les Abymes, Guadeloupe.
Cédric RamdiniService de Lutte Anti-Vectorielle, Agence Régionale de Santé, Dothémare, Les Abymes, Guadeloupe.
Joël GustaveService de Lutte Anti-Vectorielle, Agence Régionale de Santé, Dothémare, Les Abymes, Guadeloupe.
Florence FouqueLaboratory of Medical Entomology, Unit Environment and Health, Institut Pasteur de la Guadeloupe, 97183 Les Abymes, Guadeloupe; Vector Environment and Society Unit, Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, 20, Avenue Appia, CH-1211 Geneva 27, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundIn Guadeloupe, Aedes aegypti mosquitoes are the only vectors of dengue and chikungunya viruses. For both diseases, vector control is the only tool for preventing epidemics since no vaccine or specific treatment is available. However, to efficiently implement control of mosquitoes vectors, a reliable estimation of the transmission risks is necessary. To become infective an Ae. aegypti female must ingest the virus during a blood meal and will not be able to transmit the virus during another blood-meal until the extrinsic incubation period is completed. Consequently the aged females will carry more infectious risks. The objectives of the present study were to estimate under controlled conditions the expectation of infective life for females and thus the transmission risks in relation with their reproductive cycle and parity status. METHODOLOGY/PRINCIPAL

findingsLarvae of Ae. aegypti were collected in central Guadeloupe and breed under laboratory conditions until adult emergence. The experiments were performed at constant temperatures (± 1.5°C) of 24°C, 27°C and 30°C on adults females from first generation (F1). Females were kept and fed individually and records of blood-feeding, egg-laying and survival were done daily. Some females were dissected at different physiological stages to observe the ovaries development. The data were analyzed to follow the evolution of parity rates, the number of gonotrophic cycles, the fecundity and to study the mean expectation of life and the mean expectation of infective life for Ae. aegypti females according to temperatures. The expectation of life varies with the parity rates and according to the temperatures, with durations from about 10 days at low parity rates at the higher temperature to an optimal duration of about 35 days when 70% of females are parous at 27°C. Infective life expectancy was found highly variable in the lower parous rates and again the optimal durations were found when more than 50% of females are parous for the mean temperatures of 27°C and 30°C.

conclusionParity rates can be determined for field collected females and could be a good proxy of the expectation of infective life according to temperatures. However, for the same parity rates, the estimation of infective life expectation is very different between Ae. aegypti and Anopheles gambiae mosquitoes. Correlation of field parity rates with transmission risks requires absolutely to be based on Ae. aegypti models, since available Anopheles sp. models underestimate greatly the females longevity.

Indexed as

Insect VectorsAedesAnimalsDengueFemaleFertilityGuadeloupeHumansLarvaLongevityMaleOvaryParityReproductionRiskTemperature

Identifiers

PMID26258684
PMCPMC4530937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.